Advanced Wound Care Market Report 2026

Advanced Wound Care Market Overview

• Advanced Wound Care market size has reached to $11.61 billion in 2025 • Expected to grow to $16.43 billion in 2030 at a compound annual growth rate (CAGR) of 7.2% • Growth Driver: Diabetes Prevalence Fuels The Advanced Wound Care Devices Market • Market Trend: Portable Negative Pressure Therapy For Home-Based Management • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Advanced Wound Care Market?

Advanced wound care devices refer to treatment devices and goods that used to speed the recovery of skin infections, abrasions, blisters, cracks, craters, necrosis, and or ulcers. It is based on moisture therapy, which distributes moisture to the affected area. This promotes spontaneous cell repair while allowing the wound to breathe. The main types of advanced wound care devices are moist, antimicrobial, and active. Antimicrobial refers to agents that kill or prevent the development of microorganisms such as spores, bacteria, or protozoa and are used to kill bacteria in wounds. These are used in various applications such as chronic wounds, and acute wounds and by various end users such as hospitals, specialty clinics, home healthcare, and others.

What Is The Advanced Wound Care Market Growth Forecast?

The advanced wound care market size is expected to see strong growth in the next few years. It will grow to $16.43 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to increasing demand for advanced wound healing solutions, rising adoption of home healthcare wound management, expansion of personalized wound treatment approaches, growing focus on reducing healing time, increasing investment in wound care innovation. Major trends in the forecast period include increasing adoption of moist wound healing technologies, rising use of antimicrobial and active dressings, growing integration of npwt systems, expansion of bioengineered skin substitutes, enhanced focus on chronic wound management.

Global Advanced Wound Care Market Segmentation

1) By Product: Moist, Antimicrobial, Active 2) By Application: Chronic Wounds, Acute Wounds 3) By End User: Hospitals, Specialty Clinics, Home Healthcare, Other End Users Subsegments: 1) By Moist: Hydrocolloid Dressings, Hydrogels, Foam Dressings 2) By Antimicrobial: Silver-Infused Dressings, Honey-Infused Dressings, Iodine-Containing Dressings 3) By Active: Negative Pressure Wound Therapy (NPWT), Bioengineered Skin Substitutes

What Is The Driver Of The Advanced Wound Care Market?

The growing prevalence of diabetes is expected to boost the growth of the advanced wound care devices market going forward. Diabetes is a chronic medical condition characterized by elevated levels of blood glucose (blood sugar) resulting from the body's inability to produce or effectively use insulin, a hormone responsible for regulating blood sugar. The increasing prevalence of diabetes drives a heightened demand for specialized advanced wound care devices, emphasizing the necessity for continuous innovation and investment in technologies to address the unique challenges posed by diabetic wounds and enhance patient outcomes. Advanced wound care helps diabetes by promoting faster healing of chronic wounds, reducing the risk of infections, preventing complications like ulcers or amputations, and improving overall skin health in diabetic patients. For instance, in June 2024, according to the National Health Service, a UK-based government department, in 2023, the NHS identified over half a million (549,000) additional individuals in England at risk of developing type 2 diabetes, bringing the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This represents a significant increase compared to 3,065,825 in 2022, highlighting a rise of nearly 20%. Therefore, the growing prevalence of diabetes is driving the growth of the advanced wound care devices market.

Key Players In The Global Advanced Wound Care Market

Major companies operating in the advanced wound care market are Integra LifeSciences Corp., Mölnlycke Health Care, Johnson & Johnson Services Inc., Medline Industries Inc., Medtronic plc, Organogenesis Holdings Inc., Smith & Nephew plc, B. Braun Melsungen AG, Coloplast A/S, ConvaTec Group plc, Hollister Incorporated, URGO Medical Ltd., Lohmann & Rauscher GmbH & Co. KG, MiMedx Group Inc., BSN medical GmbH, Paul Hartmann AG, Johnson & Johnson Medical Devices Group, Beiersdorf AG, Zimmer Biomet Holdings Inc., Misonix Inc., Cardinal Health Inc., Nestlé Health Science SA, Becton Dickinson and Company

Global Advanced Wound Care Market Trends and Insights

Major companies operating in the advanced wound care market are focusing on developing innovative solutions, such as portable, patient‑friendly negative pressure wound therapy (NPWT) systems, to meet the rising demand for more accessible and home‑based chronic wound management as healthcare shifts toward outpatient settings and remote care. Negative pressure wound therapy involves applying controlled suction (sub‑atmospheric pressure) to wounds to promote healing by removing exudate, reducing edema, and stimulating tissue growth unlike traditional dressings, NPWT provides active, continuous management rather than passive coverage. For instance, in April 2024, Smith+Nephew PLC, a UK‑based medical‑technology company, launched the RENASYS EDGE NPWT System in the U.S., a compact, lightweight, and quiet device designed for chronic wound patients at home. The system’s discreet canister and near‑field communication interface make it user‑friendly and allow step-by-step guidance for setup; it operates quietly so as not to draw attention, supports continuous therapy in an ambulatory environment, and is backed by 24‑hour clinical support. Smith+Nephew also partnered with national distributors (SunMED Medical Solutions and First Nation Group) to make the device more widely available, thereby enhancing patient independence and adherence.

What Are Latest Mergers And Acquisitions In The Advanced Wound Care Market?

In July 2023, Coloplast A/S, a Denmark‑based healthcare technology company, acquired Kerecis Limited for up to $1.3 billion. With this acquisition, Coloplast A/S aimed to strategically strengthen its position in the advanced wound care market by entering the high-growth, U.S.-centric biologics segment. Kerecis Limited is an Iceland‑based biotechnology company that specializes in providing intact fish-skin–based soft tissue regeneration products for wound healing, using a patented platform that retains natural skin structure to support chronic, surgical, and burn wound repair.

Regional Outlook

North America was the largest region in the advanced wound care devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the advanced wound care devices market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Advanced Wound Care Market?

The advanced wound care devices the market consists of sales of wound bandages, medical bandage rolls, and dressing packs. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.